Oncology Time to level the playing field for men with prostate cancer Prostate cancer affects not just patients, but their families too.
Oncology Could cancer be the next mRNA breakthrough? mRNA vaccines achieved their first success against COVID-19, but could a cancer target be next?
Oncology Optimised cancer drug dosing - FDA guidelines’ quantum leap Dose optimisation guidance for clinical trials was released by the FDA this January.
Oncology The future is now: AI and more effective cancer screening Ben Hargreaves examines how AI cancer diagnosis is currently being implemented, and how it could evolve in the years ahead, including the potential for the exploration of digital biomarkers
Oncology Need for non-melanoma skin cancer guideline never greater Non-melanoma skin cancer (NMSC) is the most common cancer in the UK, more than breast, bowel, and prostate cancer combined.
Digital Tackling ongoing staffing burnout rates through AI-enabled p... The emergence of COVID-19 resulted in staffing challenges that have continued to have a sustained, negative impact on clinical trial workflows.
News Heart drug developer Kardigan files IPO The steady stream of biotech IPOs on the Nasdaq this year has continued, with Kardigan the latest to make its intention to list known.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
